International Journal of Gynecologic Cancer: 29 (2)

Editorial

Pre-operative evaluation in advanced ovarian cancer: is ultrasound ready to replace computed tomography? (4 February, 2019) Free
Debora Verri

Original Article

Pre-operative assessment of intra-abdominal disease spread in epithelial ovarian cancer: a comparative study between ultrasound and computed tomography (10 January, 2019)
Juan Luis Alcázar, María Caparros, Maria Arraiza, José Ángel Mínguez, Stefano Guerriero, Luis Chiva, Matías Jurado

Preinvasive Disease

Role of HPV genotyping in risk assessment among cytology diagnosis categories: analysis of 4562 cases with cytology–HPV cotesting and follow-up biopsies (18 January, 2019)
Yimin Ge, Paul Christensen, Eric Luna, Donna Armylagos, Jiaqiong Xu, Mary R Schwartz, Dina R Mody
Association of human papillomavirus and bacterial vaginosis with increased risk of high-grade squamous intraepithelial cervical lesions (10 January, 2019)
Tamy Tiemi Suehiro, Natália Malaguti, Edilson Damke, Nelson Shozo Uchimura, Fabrícia Gimenes, Raquel Pantarotto Souza, Vânia Ramos Sela da Silva, Marcia Edilaine Lopes Consolaro
Persuasive messaging for human papillomavirus vaccination by adolescent providers in a five-country multi-site study (4 January, 2019)
Janvier Rwamwejo, Silvina Ramos, Karen Morgan, Karin Richter, Chan Joo Kim, Mercè Peris, Jennifer S Smith

Cervical Cancer

Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer (10 January, 2019)
Nanda Horeweg, Carien L Creutzberg, Eva C Rijkmans, Mirjam S Laman, Laura A Velema, Veronique L M A Coen, Tanja C Stam, Ellen M Kerkhof, Judith R Kroep, Cor D de Kroon, Remi A Nout
The role of positron emission tomography in the selection of patients for salvage hysterectomy following chemoradiotherapy for locally advanced cervical cancer (10 January, 2019)
Chrishanthi Rajasooriyar, Ming-Yin Lin, Rashi Kalra, Andrew Lim, Kailash Narayan
Capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: a retrospective study (13 January, 2019)
Giuseppa Maltese, Stefano Lepori, Ilaria Sabatucci, Elisa Tripodi, Domenica Lorusso

Endometrial Cancer

Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma (13 January, 2019)
Mitsumasa Osakabe, Daisuke Fukagawa, Chie Sato, Ryo Sugimoto, Noriyuki Uesugi, Kazuyuki Ishida, Hiroaki Itamochi, Toru Sugiyama, Tamotsu Sugai
Does lymphadenectomy improve survival in patients with intermediate risk endometrial cancer? A multicentric study from the FRANCOGYN Research Group (21 December, 2018)
Lilia Bougherara, Henri Azaïs, Hélène Béhal, Geoffroy Canlorbe, Marcos Ballester, Sofiane Bendifallah, Charles Coutant, Vincent Lavoue, Lobna Ouldamer, Olivier Graesslin, Cyril Touboul, Juan Pablo Estevez, Pierre Collinet
The association between histological subtype of a first primary endometrial cancer and second cancer risk (21 December, 2018)
Jennifer Rhoades, Monica Hagan Vetter, James L Fisher, David E Cohn, Ritu Salani, Ashley S Felix
Vaginal hysterectomy with or without bilateral salpingo-oophorectomy may be an alternative treatment for endometrial cancer patients with medical co-morbidities precluding standard surgical procedures: a systematic review (18 January, 2019)
Arnold-Jan Kruse, Henk G ter Brugge, Harm H de Haan, Hugo W Van Eyndhoven, Hans W Nijman
DNA ploidy status, S-phase fraction, and p53 are not independent prognostic factors for survival in endometrioid endometrial carcinoma FIGO stage I–III (13 January, 2019)
Teresia Svanvik, Ulf Strömberg, Erik Holmberg, Janusz Marcickiewicz, Karin Sundfeldt
Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience (18 January, 2019)
Lavinia Volpi, Giulio Sozzi, Vito Andrea Capozzi, Matteo Ricco’, Carla Merisio, Maurizio Di Serio, Vito Chiantera, Roberto Berretta
A novel prediction method for lymph node involvement in endometrial cancer: machine learning (28 December, 2018)
Emre Günakan, Suat Atan, Asuman Nihan Haberal, İrem Alyazıcı Küçükyıldız, Ehad Gökçe, Ali Ayhan

Ovarian Cancer

Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients (29 January, 2019)
Saul Eugene Rivkin, James Moon, Desiree S Iriarte, Erik Bailey, Heather L Sloan, Gary E Goodman, Amy E BonDurant, Dan Velijovich, Tanya Wahl, Peter Jiang, Chirag A Shah, Charles Drescher, Mehmet F Fer, Henry G Kaplan, Erin D Ellis
Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer (4 January, 2019)
Lan Ying Li, Sang Wun Kim, Eun Ji Nam, JungYun Lee, Sunghoon Kim, Young Tae Kim
Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancer (23 January, 2019)
Robert D Morgan, Andrew R Clamp, Cong Zhou, Geoff Saunders, Nerissa Mescallado, Richard Welch, Claire Mitchell, Jurjees Hasan, Gordon C Jayson
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses
(18 January, 2019)
Victoria Mandilaras, Swati Garg, Michael Cabanero, Qian Tan, Chiara Pastrello, Julia Burnier, Katherine Karakasis, Lisa Wang, Neesha C Dhani, Marcus O Butler, Philippe L Bedard, Lillian L Siu, Blaise Clarke, Patricia Ann Shaw, Tracy Stockley, Igor Jurisica, Amit M Oza, Stephanie Lheureux
Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results (25 January, 2019)
Steffen Böhm, Nhu Le, Michelle Lockley, Elly Brockbank, Asma Faruqi, Ian Said, Arjun Jeyarajah, Rekha Wuntakal, Blake Gilks, Naveena Singh
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer (25 January, 2019)
Jennifer Taylor Veneris, Lei Huang, Jane E Churpek, Suzanne D Conzen, Gini F Fleming
Patterns of care and outcomes for women with uterine cancer and ovarian metastases (4 January, 2019)
Nathaniel L Jones, Yongmei Huang, Sudeshna Chatterjee, Ana I Tergas, William M Burke, June Y Hou, Israel Deutsch, Cande V Ananth, Alfred I Neugut, Dawn L Hershman, Jason D Wright
Clinical application of the sentinel lymph node technique in early ovarian cancer: a pilot study (21 December, 2018)
V Lago, P Bello, B Montero, L Matute, P Padilla-Iserte, S Lopez, M Agudelo, S Domingo
Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis (23 January, 2019)
Martina Aida Angeles, François Quenet, Pierre Vieille, Laurence Gladieff, Jean Ruiz, Muriel Picard, Federico Migliorelli, Leonor Chaltiel, Carlos Martínez-Gómez, Alejandra Martinez, Gwénaël Ferron
Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer (21 January, 2019)
Maite Timmermans, G S Sonke, K K Van de Vijver, P B Ottevanger, H W Nijman, M A van der Aa, R F P M Kruitwagen
Are omentectomy and lymphadenectomy necessary in patients with apparently early-stage malignant ovarian germ cell tumors? (23 January, 2019)
Beijiao Qin, Wenyan Xu, Yanfang Li

Review Articles

Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article (18 January, 2019)
Charlotte Maggen, Mathilde van Gerwen, Kristel Van Calsteren, Tineke Vandenbroucke, Frédéric Amant
A report on the Marrakech International Women’s Cancer Days: dialogs and implications (21 December, 2018)
Sara Nasser, Jonathan Berek, Andreas Ullrich, Livia Giordano, Jalid Sehouli
Reviewing vulvar Paget’s disease molecular bases. Looking forward to personalized target therapies: a matter of CHANGE (23 January, 2019)
Giulia Mantovani, Anna Fagotti, Massimo Franchi, Giovanni Scambia, Giorgia Garganese

Clinical Trial

Trials in progress: IMagyn050/GOG 3015/ENGOT-OV39. A Phase III, multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer (10 January, 2019)
Kathleen N Moore, Sandro Pignata

Case Study

Conservative management of cervical cancer in pregnancy (23 January, 2019) Free
Pedro T Ramirez, Nadeem R Abu-Rustum, Elizabeth Euscher

Corners of the World

Improving the quality of care in a public hospital in Guatemala (23 January, 2019) Free
Erick Estuardo Estrada

Video Articles

The anatomical structure of the paravesico-vaginal space, a novel landmark for nerve-sparing radical hysterectomy (18 January, 2019) Free
Sheng Yin, Si-Ning Ma, Rong-Yu Zang
How to perform a laparoscopic pelvic sentinel lymph node dissection using near-infrared fluorescence with indocyanine green in gynecological cancers (18 January, 2019) Free
Elie Vésale, Henri Azaïs, Jérémie Belghiti, Maryam Nikpayam, Catherine Uzan, Geoffroy Canlorbe
Inguino-abdominal combined approach for laterally extended pelvic resection: a step by step procedure (4 February, 2019) Free
Giuseppe Vizzielli, Emanuele Perrone, Alessandro Gioè, Giovanni Tinelli, Giovanni Scambia

Main menu

Table of contents

February 2019 - Volume 29 - 2

Editorial

Original Article

Preinvasive Disease

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

Review Articles

Clinical Trial

Case Study

Corners of the World

Video Articles

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

February 2019 - Volume 29 - 2

Editorial

Original Article

Preinvasive Disease

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

Review Articles

Clinical Trial

Case Study

Corners of the World

Video Articles

Issue Information